CUV.AX vs. BABA

Last updated Jun 4, 2026

CUV.AX (Clinuvel Pharmaceuticals Limited) and BABA (Alibaba Group Holding Limited) are both stocks. CUV.AX operates in Biotechnology (Healthcare), while BABA operates in Internet Retail (Consumer Cyclical). Over the past 10 years, CUV.AX returned 7.01%/yr vs 6.10%/yr for BABA. At a 0.03 correlation, their price movements are largely independent.

Performance

CUV.AX vs. BABA - Performance Comparison

The chart below illustrates the hypothetical performance of a A$10,000 investment in Clinuvel Pharmaceuticals Limited (CUV.AX) and Alibaba Group Holding Limited (BABA). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CUV.AX is traded in AUD, while BABA is traded in USD. To make them comparable, the BABA values have been converted to AUD using the latest available exchange rates.

Returns By Period

In the year-to-date period, CUV.AX achieves a -29.13% return, which is significantly lower than BABA's -18.76% return. Over the past 10 years, CUV.AX has outperformed BABA with an annualized return of 7.01%, while BABA has yielded a comparatively lower 6.10% annualized return.

CUV.AX

• 1D: -1.89%
• 1M: -4.54%
• YTD: -29.13%
• 6M: -27.38%
• 1Y: -10.38%
• 3Y*: -21.15%
• 5Y*: -20.83%
• 10Y*: 7.01%

BABA

• 1D: -2.31%
• 1M: -4.03%
• YTD: -18.76%
• 6M: -25.48%
• 1Y: 2.04%
• 3Y*: 13.78%
• 5Y*: -7.86%
• 10Y*: 6.10%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CUV.AX vs. BABA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CUV.AX Clinuvel Pharmaceuticals Limited	-29.13%	3.82%	-24.38%	-25.96%	-20.20%	21.99%	-21.45%	57.33%	121.24%	9.93%
BABA Alibaba Group Holding Limited	-18.76%	63.03%	23.02%	-10.76%	-20.94%	-45.97%	0.09%	55.46%	-11.98%	81.41%

Correlation

The correlation between CUV.AX and BABA is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.05
Correlation (3Y) Calculated over the trailing 3-year period	-0.00
Correlation (5Y) Calculated over the trailing 5-year period	0.03
Correlation (10Y) Calculated over the trailing 10-year period	0.03
Correlation (All Time) Calculated using the full available price history since Sep 22, 2014	0.03

Return for Risk

CUV.AX vs. BABA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CUV.AX

CUV.AX Risk / Return Rank: 31
CUV.AX Sharpe Ratio Rank: 31
CUV.AX Sortino Ratio Rank: 30
CUV.AX Omega Ratio Rank: 30
CUV.AX Calmar Ratio Rank: 32
CUV.AX Martin Ratio Rank: 31

BABA

BABA Risk / Return Rank: 48
BABA Sharpe Ratio Rank: 50
BABA Sortino Ratio Rank: 49
BABA Omega Ratio Rank: 45
BABA Calmar Ratio Rank: 48
BABA Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CUV.AX vs. BABA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clinuvel Pharmaceuticals Limited (CUV.AX) and Alibaba Group Holding Limited (BABA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CUV.AX	BABA	Difference
Sharpe ratio: Return per unit of total volatility	-0.23	0.05	-0.28
Sortino ratio: Return per unit of downside risk	-0.03	0.42	-0.45
Omega ratio: Gain probability vs. loss probability	1.00	1.04	-0.05
Calmar ratio: Return relative to maximum drawdown	-0.29	0.05	-0.34
Martin ratio: Return relative to average drawdown	-0.53	0.10	-0.63
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CUV.AX vs. BABA - Sharpe Ratio Comparison

The current CUV.AX Sharpe Ratio is -0.23, which is lower than the BABA Sharpe Ratio of 0.05. The chart below compares the historical Sharpe Ratios of CUV.AX and BABA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CUV.AX	BABA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.23	0.05	-0.28
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.44	-0.16	-0.28
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.13	0.15	-0.02
Sharpe Ratio (All Time) Calculated using the full available price history	0.13	0.13	0.00

Drawdowns

CUV.AX vs. BABA - Drawdown Comparison

The maximum CUV.AX drawdown since its inception was -92.52%, which is greater than BABA's maximum drawdown of -77.79%. Use the drawdown chart below to compare losses from any high point for CUV.AX and BABA.

Drawdown Indicators

	CUV.AX	BABA	Difference
Max Drawdown Largest peak-to-trough decline	-92.52%	-77.79%	-14.73%
Max Drawdown (1Y) Largest decline over 1 year	-35.53%	-40.18%	+4.65%
Max Drawdown (3Y) Largest decline over 3 years	-58.28%	-40.18%	-18.10%
Max Drawdown (5Y) Largest decline over 5 years	-79.57%	-67.60%	-11.97%
Max Drawdown (10Y) Largest decline over 10 years	-80.18%	-77.79%	-2.39%
Current Drawdown Current decline from peak	-80.08%	-57.80%	-22.28%
Average Drawdown Average peak-to-trough decline	-56.63%	-34.25%	-22.38%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.39%	21.23%	-1.84%

Volatility

CUV.AX vs. BABA - Volatility Comparison

The current volatility for Clinuvel Pharmaceuticals Limited (CUV.AX) is 8.82%, while Alibaba Group Holding Limited (BABA) has a volatility of 13.92%. This indicates that CUV.AX experiences smaller price fluctuations and is considered to be less risky than BABA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CUV.AX	BABA	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.82%	13.92%	-5.10%
Volatility (6M) Calculated over the trailing 6-month period	31.00%	27.72%	+3.28%
Volatility (1Y) Calculated over the trailing 1-year period	44.40%	41.91%	+2.49%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	46.91%	48.37%	-1.46%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	52.81%	41.22%	+11.59%

Dividends

CUV.AX vs. BABA - Dividend Comparison

CUV.AX's dividend yield for the trailing twelve months is around 0.57%, less than BABA's 1.57% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
BABA Alibaba Group Holding Limited	1.57%	1.36%	1.96%	1.29%	0.00%	0.00%	0.00%	0.00%	0.00%
CUV.AX Clinuvel Pharmaceuticals Limited	0.57%	0.40%	0.41%	0.31%	0.18%	0.09%	0.11%	0.09%	0.11%

Financials

Frequently Asked Questions

Can I hold both CUV.AX and BABA in my portfolio?

CUV.AX and BABA have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.